Literature DB >> 11306439

Alveolar macrophages, surfactant lipids, and surfactant protein B regulate the induction of immune responses via the airways.

J F van Iwaarden1, E Claassen, S H Jeurissen, H P Haagsman, G Kraal.   

Abstract

The influences of alveolar macrophages (AM) and pulmonary surfactant on the induction of immune responses via the airways were assessed. Mice were depleted of their AM by intratracheal instillation of multilamellar vesicles containing dichloromethylene-diphosphonate followed by intratracheal instillation of a T cell--dependent antigen, trinitrophenyl--keyhole limpet hemocyanin, in vesicles of various compositions. The primary immune response was determined in the spleen of these animals using an ELI-Spot assay. The secondary immune responses in the sera of the mice were assessed using enzyme-linked immunosorbent assays. An immune response was detected in animals depleted of their AM and intratracheally instilled with antigen in small unilamellar vesicles consisting of either phosphatidylcholine cholesterol or surfactant lipids. Incorporation of surfactant protein (SP)-B in the antigen vesicles enhanced the immune response, whereas SP-A or SP-C in the antigen vesicle did not have an effect. Strikingly, intratracheal instillation of SP-B containing antigen vesicles can induce an immunoglobulin M immune response in mice without depletion of AM. These results indicate that SP-B containing vesicles can enhance the induction of immune responses via the airways and further illustrate the important roles of both AM and pulmonary surfactant in the pulmonary immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306439     DOI: 10.1165/ajrcmb.24.4.4239

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  6 in total

1.  Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV).

Authors:  A Benoit; Y Huang; J Proctor; G Rowden; R Anderson
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS.

Authors:  Marla R Wolfson; Jichuan Wu; Terrence L Hubert; Timothy J Gregory; Jan Mazela; Thomas H Shaffer
Journal:  Pediatr Res       Date:  2012-07-20       Impact factor: 3.756

3.  Toxicoproteomic analysis of pulmonary carbon nanotube exposure using LC-MS/MS.

Authors:  Gina M Hilton; Alexia J Taylor; Christina D McClure; Gregory N Parsons; James C Bonner; Michael S Bereman
Journal:  Toxicology       Date:  2015-01-15       Impact factor: 4.221

4.  Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

Authors:  M G Foreman; D L DeMeo; C P Hersh; V J Carey; V S Fan; J J Reilly; S D Shapiro; E K Silverman
Journal:  Eur Respir J       Date:  2008-06-11       Impact factor: 16.671

5.  SP-A2 contributes to miRNA-mediated sex differences in response to oxidative stress: pro-inflammatory, anti-apoptotic, and anti-oxidant pathways are involved.

Authors:  George T Noutsios; Nithyananda Thorenoor; Xuesheng Zhang; David S Phelps; Todd M Umstead; Faryal Durrani; Joanna Floros
Journal:  Biol Sex Differ       Date:  2017-12-04       Impact factor: 5.027

Review 6.  Metabolic influence on macrophage polarization and pathogenesis.

Authors:  Bikash Thapa; Keunwook Lee
Journal:  BMB Rep       Date:  2019-06       Impact factor: 4.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.